Net Cash Settlement Amount = Cash Settlement Amount - Exercise Expense Charged by Issuer By; In case of Call Warrant and Underlying Asset is Stock :
Cash Settlement Amount = (Settlement Price - Exercise Price) X Exercise Ratio In case of Put Warrant and Underlying Asset is Stock :
Cash Settlement Amount = (Exercise Price - Settlement Price) X Exercise Ratio In case of Call Warrant and Underlying Asset is Index :
Cash Settlement Amount = (Settlement Price - Exercise Price) X Multiplier In case of Put Warrant and Underlying Asset is Index :
Cash Settlement Amount = (Exercise Price - Settlement Price) X Multiplier In case of Call Warrant and Underlying Asset is Foreign Stock :
Cash Settlement Amount = (Settlement Price - Exercise Price) X Exercise Ratio X Exchange rate In case of Put Warrant and Underlying Asset is Foreign Stock :
Cash Settlement Amount = (Exercise Price - Settlement Price) X Exercise Ratio X Exchange rate In case of Call Warrant and Underlying Asset is Foreign Index :
Cash Settlement Amount = (Settlement Price - Exercise Price) X Multiplier X Exchange rate In case of Put Warrant and Underlying Asset is Foreign Index :
Cash Settlement Amount = (Exercise Price - Settlement Price) X Multiplier X Exchange rate
Any Derivative Warrant (DW) will automatically be exercised if the Net Cash Settlement Amount on the Automatic Exercise Date is greater than zero (without notice being given to the Holders). The Issuer will pay to the Holders the Net Cash Settlement Amount (if any) with procedure defined in Terms and Condition.
The Holders can deny the exercise of DW by informing their broker in accordance with procedures stipulated by their broker.
Signature ________________________________
(Mr.Krit Naowarattipakorn)
Vice President
Authorized Persons to Disclose Information
This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chularat Hospital pcl published this content on 27 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2022 11:03:07 UTC.
Chularat Hospital Public Company Limited is a Thailand-based company that is engaged in the operations of clinics and hospitals. The Company operates through two segments: hospital operations, and other businesses, which support hospital business including distribution of medical instruments. Its hospital operation includes Orthopedic and Micro Vascular Clinic, Neonatal Intensive-Care Unit, Stroke Center, Skin Center and Cosmetics Surgery, Minimally Invasive Surgery - MIS, Comprehensive Heart Center, Integrated Cancer Center, Prostate Cancer Center using Brachytherapy, The New Baby Fertility Center and Suvarnabhumi Eye Center. Its three hospitals provide secondary care services: Chularat 3 International Hospital, Chularat 9 Airport Hospital and Chularat 11 International Hospital. It imports and supplies surgical and medical equipment, such as electric surgery beds, heart rate counter and others. The Company provides spa services under the name Chularat Thai Traditional Medicine.